Overview of the Deal In a strategic move to expand its domestic prescription portfolio, Aurobindo Pharma has agreed to acquire the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd. The transaction is structured as a going-concern slump sale for a cash consideration of Rs 325 crore. The deal underscores the growing importance of consolidating…